EXTENDING THE SUSCEPTIBLE-EXPOSED-INFECTED-REMOVED(SEIR) MODEL TO HANDLE THE HIGH FALSE NEGATIVE RATE AND SYMPTOM-BASED ADMINISTRATION OF COVID-19 DIAGNOSTIC TESTS: SEIR-fansy.


Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
25 Sep 2020
Historique:
entrez: 30 9 2020
pubmed: 1 10 2020
medline: 1 10 2020
Statut: epublish

Résumé

The false negative rate of the diagnostic RT-PCR test for SARS-CoV-2 has been reported to be substantially high. Due to limited availability of testing, only a non-random subset of the population can get tested. Hence, the reported test counts are subject to a large degree of selection bias. We consider an extension of the Susceptible-Exposed-Infected-Removed (SEIR) model under both selection bias and misclassification. We derive closed form expression for the basic reproduction number under such data anomalies using the next generation matrix method. We conduct extensive simulation studies to quantify the effect of misclassification and selection on the resultant estimation and prediction of future case counts. Finally we apply the methods to reported case-death-recovery count data from India, a nation with more than 5 million cases reported over the last seven months. We show that correcting for misclassification and selection can lead to more accurate prediction of case-counts (and death counts) using the observed data as a beta tester. The model also provides an estimate of undetected infections and thus an under-reporting factor. For India, the estimated under-reporting factor for cases is around 21 and for deaths is around 6. We develop an R-package (SEIRfansy) for broader dissemination of the methods.

Identifiants

pubmed: 32995829
doi: 10.1101/2020.09.24.20200238
pmc: PMC7523173
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : P30 CA046592
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

JAMA. 2020 Apr 21;323(15):1437-1438
pubmed: 32150622
Mayo Clin Proc. 2020 Jun;95(6):1127-1129
pubmed: 32376102
BMC Med Res Methodol. 2020 Jun 6;20(1):146
pubmed: 32505172
Int Stat Rev. 2020 Aug;88(2):462-513
pubmed: 32834402
N Engl J Med. 2020 Aug 6;383(6):e38
pubmed: 32502334
Harv Data Sci Rev. 2020;2020(Suppl 1):
pubmed: 32607504
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Ann Intern Med. 2020 May 5;172(9):577-582
pubmed: 32150748
Emerg Infect Dis. 2020 May;26(5):1052-1054
pubmed: 32091386
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
JAMA. 2020 May 19;323(19):1915-1923
pubmed: 32275295
Infect Dis Model. 2017 Jun 29;2(3):288-303
pubmed: 29928743
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
Nature. 2020 Aug;584(7821):420-424
pubmed: 32674112

Auteurs

Ritwik Bhaduri (R)

Indian Statistical Institute Kolkata, India.

Ritoban Kundu (R)

Indian Statistical Institute, Kolkata, India.

Soumik Purkayastha (S)

Department of Biostatistics, University of Michigan, Ann Arbor, USA.

Michael Kleinsasser (M)

Department of Biostatistics, University of Michigan, Ann Arbor, USA.

Lauren J Beesley (LJ)

Department of Biostatistics, University of Michigan, Ann Arbor, USA.

Bhramar Mukherjee (B)

Department of Biostatistics and Epidemiology, University of Michigan, Ann Arbor, USA.

Classifications MeSH